8-K: Cardlytics Announces First Quarter 2025 Financial Results

Cardlytics reports an 8% year-over-year decrease in revenue for Q1 2025, alongside a 7% decrease in billings, but highlights progress in key business pillars.

Summary

• Cardlytics announced its financial results for the first quarter ended March 31, 2025.
• Revenue decreased by 8% year-over-year to $61.9 million from $67.6 million.
• Billings decreased by 7% year-over-year to $97.6 million from $105.2 million.
• Adjusted Contribution decreased by 12% year-over-year to $32.4 million from $37.1 million.
• Net Loss was $(13.3) million, or $(0.26) per diluted share, compared to a Net Loss of $(24.3) million, or $(0.56) per diluted share in the first quarter of 2024.
• Adjusted EBITDA was $(4.4) million compared to $0.2 million in the first quarter of 2024.
• Net cash used in operating activities was $(6.7) million, compared to $(17.6) million in the first quarter of 2024.
• Free Cash Flow was $(10.8) million, compared to $(22.4) million in the first quarter of 2024.
• Cardlytics monthly qualified users (MQUs) were 214.9 million, an increase of 12% year-over-year.
• Cardlytics adjusted contribution per user (ACPU) was $0.13 compared to $0.17 in the first quarter of 2024.
• For the second quarter of 2025, Cardlytics anticipates billings between $100.0 and $108.0 million, revenue between $61.0 and $67.0 million, adjusted contribution between $32.5 and $36.5 million, and adjusted EBITDA between $(4.0) and $1.0 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company highlights progress in key areas and improved net loss, the overall financial performance shows declines in revenue, billings, and adjusted contribution. The guidance for Q2 2025 suggests continued challenges.

Positives

• Net loss improved significantly, decreasing from $(24.3) million in Q1 2024 to $(13.3) million in Q1 2025.
• Net cash used in operating activities decreased from $(17.6) million to $(6.7) million year-over-year.
• MQUs increased by 12% year-over-year, indicating growth in user base.
• Management is focused on strengthening the balance sheet and disciplined cost management.

Negatives

• Revenue decreased by 8% year-over-year.
• Billings decreased by 7% year-over-year.
• Adjusted Contribution decreased by 12% year-over-year.
• Adjusted EBITDA was negative at $(4.4) million, compared to $0.2 million in the first quarter of 2024.
• ACPU decreased from $0.17 to $0.13 year-over-year.

Risks

• Unfavorable conditions in the global economy, including inflationary pressure and trade protection measures, could impact results.
• The company's quarterly operating results have fluctuated and may continue to vary.
• Cardlytics is substantially dependent on its Cardlytics platform and a limited number of financial institution partners.
• The amount and timing of budgets by marketers are affected by budget cycles, economic conditions, and other factors.
• The company's ability to adapt to changing market conditions and compete successfully is crucial.

Future Outlook

Cardlytics anticipates for Q2 2025: Billings of $100.0 $108.0 million, Revenue of $61.0 $67.0 million, Adjusted Contribution of $32.5 $36.5 million, and Adjusted EBITDA of $(4.0) $1.0 million.

Management Comments

• 'We've made marked progress across our key business pillars, which continue to underpin our journey to 'platformize' Cardlytics and position ourselves as the leading commerce media platform,' said Amit Gupta, CEO of Cardlytics.
• 'Weve built a resilient platform and are making strategic decisions as we look to future-proof our business,' said Alexis DeSieno, CFO of Cardlytics.
• The CFO also mentioned taking a targeted, disciplined approach to cost management while continuing to invest in key areas for growth.

Industry Context

Cardlytics operates in the competitive digital advertising space, facing challenges from established players and evolving consumer habits. The company's focus on leveraging transaction data from financial institutions differentiates it, but it must continue to innovate and adapt to maintain its position.

Comparison to Industry Standards

• Cardlytics' performance can be compared to other digital advertising platforms such as The Trade Desk (TTD) and PubMatic (PUBM).
• While TTD and PUBM focus on the buy and sell sides of programmatic advertising, respectively, Cardlytics carves a niche by leveraging financial transaction data.
• Compared to companies like LiveRamp (RAMP) that focus on data connectivity, Cardlytics provides a more direct link to consumer spending behavior through its partnerships with financial institutions.
• The decrease in revenue and billings contrasts with the growth seen in some parts of the digital advertising sector, indicating potential challenges in market share or specific business model pressures.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and billings, but encouraged by the improved net loss.
• Employees may be affected by the company's cost management efforts.
• Financial institution partners will be interested in the growth of MQUs and the company's ability to drive customer engagement.
• Marketers will be focused on the effectiveness of Cardlytics' platform in reaching and influencing consumers.

Next Steps

• Cardlytics will hold a live audio webcast on May 7, 2025, to discuss the first quarter 2025 financial results.
• The company will continue to focus on strengthening its business and market position through strategic initiatives.

Key Dates

Keywords

Cardlytics, financial results, digital advertising, commerce media, billings, revenue, adjusted EBITDA, net loss, MQUs, ACPU